AI Assistant
Blog
Pricing
Log In
Sign Up
A preliminary estimate of survival gain and cost-effectiveness of CAR-T in adult patients with acute lymphoblastic leukemia
Details
Cite
Export
Add to List
This content is not available in your region!
Continue researching
here.